- Projects & figures
- News & Events
- Managing your project
- About ERC
Until recently, lungs were believed to be sterile, but today we know that they are inhabited by microbes migrating from the mouth. Dr Randi Bertelsen has been awarded an ERC grant to investigate the role played by the oral microbiome in lung disease.
The ERC-funded ONOFF project is building upon previous efforts to better understand auditory hallucinations (AH) in patients with schizophrenia. Its results could lead to new cognitive and pharmacological treatments.
ELECTION SERIES #2
Because the European Parliament represents such a diverse group of people, with different cultural and political backgrounds, it is the perfect ground to understand how gender equality operates in the halls of power. ERC grantee Johanna Kantola and her team have shadowed many members of Parliament and their teams, to study gender practices and policies inside Europe’s legislative machine.
At the forefront of medicine, gene therapy is based on the insertion of genes into an individual's cells and tissues to treat a disease. Scientists are currently testing several approaches to this experimental technique. One of them, Prof. Seppo Ylä-Herttuala, intends to develop a novel method to treat myocardial ischemia by activating endogenous genes to propel angiogenesis. If successful, he will open a new era in gene therapy.
Based on University of Turku's press release
For more than 3000 years, men have captured wild Asian elephants to use them for work or entertainment. In a new study published today in Nature Communications, ERC grantee Virpi Lummaa shows the harmful effects of these ongoing practices on wild-caught animals. The findings are based on detailed records from the past 100 years over a population of 5000 timber elephants from Myanmar.
Dr Joaquim Alves Gaspar is a man of the sea. After many years in the Portuguese Navy, he gave up plans to become an admiral in favour of pursuing a PhD in the History of Cartography. This second career led him to receive an ERC Starting Grant, the first awarded in this budding discipline. With his highly multidisciplinary team (he likes to say that, to work with him, one must be a mathematician fluent in Latin), and the experience obtained as a navigator and navigational instructor, Dr Gaspar hopes to understand how and when the first nautical charts were created. The MEDEA-CHART team is the best place in Portugal, and probably in the world, to study the history of nautical cartography, hoping that this work will provide the domain with its rightful recognition within world history.
The use and misuse of antibiotics has accelerated the emergence of drug-resistant bacterial strains, threatening our ability to treat common diseases. EU-funded research has shed new light on the mechanisms behind these microbial mutations, with implications for our understanding of diseases and resistance to treatment.
Regulating migration has become a key priority for European countries and, according to Prof. Katja Franko, crime control practices and penal cultures have evolved across the continent as a consequence. With ERC support, she has studied these new hybrid and intertwined forms of migration and crime control policies, a phenomenon she calls ‘Crimmigration control’.
Virpi Lummaa holds an Academy of Finland Professorship at the University of Turku, Finland. She is interested in ageing, lifespan and natural selection in contemporary human populations, looking at evolutionary, ecological and demographic factors. At present, Prof. Lummaa also focuses on senescence patterns of the Asian elephant, a long-lived mammal that offers unique opportunities to address ageing mechanisms. Her latest findings highlight the significant role that elephant grandmothers play to ensure the survival of the calves, providing vital baby elephant care comparable to childcare in human communities across the world.Originally published in March 2017 as part of the multimedia campaign "ERC - 10 years – 10 portraits."
Maria Brandão de Vasconcelos, together with her colleague Filipa Matos Baptista, Henrique Veiga-Fernandes (ERC grantee), Diogo Fonseca Pereira and Sílvia Arroz Madeira, founded StemCell2MAX in 2015. The company is a biotechnology start-up, specialised in cell based therapies, including novel solutions to multiply the scarcely available blood stem cells, addressing an enormous demand for research and cancer treatment. StemCell2MAX technology is based on Prof. Veiga-Fernandes's ground-breaking discoveries in hematopoietic stem cell biology.
Originally published in March 2017 as part of the multimedia campaign "ERC - 10 years – 10 portraits."